Millions of people who bought DNA tests from genetic testing service 23andme have been urged to delete their personal data ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

EU regulators are considering withdrawing market authorizations for two hair loss and enlarged prostate treatments over ...

The once-hot Silicon Valley startup has seen its stock’s value decline 99% and is struggling to survive. That has put the ...

The life sciences developer acquired the site as part of a master lease agreement with seller MIT that expires in 2099.

DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...

After 23andMe’s board of directors resigns, the president of encrypted messaging app Signal joins other security experts in ...

Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was up ...